This protocol is judged by an institutional assessment board, an independent group that opinions any clinical trials involving human beings. If a study consists of a Routine I drug, after the board approves the protocol as ethical, the scientists really have to submit an application for an investigational new drug (IND) number in the FDA.Consequent